학술논문
Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
Document Type
Article
Author
Fanouriakis, Antonis; Adamichou, Christina; Koutsoviti, Sofia; Panopoulos, Stylianos; Staveri, Chrysanthi; Klagou, Anastasia; Tsalapaki, Christina; Pantazi, Lamprini; Konsta, Styliani; Mavragani, Clio P.; Dimopoulou, Despoina; Ntali, Styliani; Katsikas, Georgios; Boki, Kyriaki A.; Vassilopoulos, Dimitrios; Konstantopoulou, Pinelopi; Liossis, Stamatis-Nick; Elezoglou, Antonia; Tektonidou, Maria; Sidiropoulos, Prodromos
Source
Seminars in Arthritis & Rheumatism; Dec2018, Vol. 48 Issue 3, p467-474, 8p
Subject
Language
ISSN
00490172
Abstract
Copyright of Seminars in Arthritis & Rheumatism is the property of W B Saunders and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)